{"id":1010315,"date":"2026-10-14T16:31:22","date_gmt":"2026-10-14T20:31:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"},"modified":"2026-10-14T16:31:22","modified_gmt":"2026-10-14T20:31:22","slug":"veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","title":{"rendered":"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Oct.  14, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pSpsg86FASUFz0YefuVC1iGC66ZuH1KaBiQgYslQW42hwErU3XqbsmCb41VEccOTvo3IhhslEmAQ9f3l2QT5RjnjlgqWPW3a78bwT54T9DM=\" rel=\"nofollow\" target=\"_blank\">Veracyte, Inc.<\/a> (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter 2026 after the close of market on Wednesday, November 4, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.<\/p>\n<p>The conference call will be webcast live from the company\u2019s website and will be available via the following link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h_7W7JxzHr2fhTDsMcu4PAVTYQ8-p_weSag7B2QWA3JRjz4VKX_Fqt5Ho1mgXOtHuewowuvIhiZEPciBjBA4oR-TRFcPNKx4_nENoTx5wmuhNBPSLvsQpq6mIHiPu1e5X8zNQvtQam7h7TnVSwNRCUfqFHSv64cVhwPS8xIE_5SmvWEyVK7Avy_Q8pAH6o84\" rel=\"nofollow\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/kgcmbvpd<\/a>. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h_7W7JxzHr2fhTDsMcu4PKBt1qf8ZMYGsaPIJeuTZbMS4xKpr5QKERTL_OFNnhfsKVn_VoK_jUJoppp5iMToZad4IifVaAqgjtuJazL00QUtjdj104BWwKqBWgxb-fSGN5B4nAGtv60m8KBWy53VlrEJjpgmsuzyaf64ReZrl9_5-8aA_ZkuoCGN7C6qV-irxtLNeNVYCOeOVTuA2Ie65ffSdBaljrK82sRqvjc70jyJzPmUBqbDMFmL9UV2IqXrlbFLiJJAZiiCqmaQiNZu8Bw1M2I-O5BQF3DPgncz5Oa2YiNIzlBIqJa3othmGtSCpLHlOFU56v5jjbLVZ6byEo8pGqujBbJ3TmNkXBvRMubeR4p3Ea4MCh8hvJxz6o1VhmtyFSqMPT5gGeqjVzDGc36bgXR2YyDazi4bZ1exwD2aFvGQpwMxtnbRxOP6QGoY4Bwkj1pYfbDyvBWBLZRXTw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.veracyte.com\/events-presentations<\/a>.<\/p>\n<p>\n        <strong>About Veracyte<br \/><\/strong>Veracyte\u00a0(Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for patients around the world. The company\u2019s molecular tests assess the unique biology of each patient\u2019s tumor to help clinicians answer essential questions about cancer care.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pSpsg86FASUFz0YefuVC1gzEcGO69qxW_lsXAT6DXsF0ZpEqgy2I4vaq9tXNe7LSg5237Iyzb3rF28FICHOuLceB8av3oMbQotuEmd9Z9OKOvsxyJQJqFdN2L_Usyyabjd4WWW7CGq3v2CWEbx9k11WxTdR2ind_qjwL9tyQVtk=\" rel=\"nofollow\" target=\"_blank\">Veracyte\u2019s Diagnostics Platform<\/a>\u00a0combines broad genomic and clinical data, advanced bioinformatics and AI, and a powerful evidence-generation engine to support continued\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=97wFaq_uDI79d6ZqwxnlWSonDrM8rYBwllTf5jNbvZCtt-jKkCDxCOjQfla2KRVKZ5rPbGUhmRo9V49b0Z-eO_8MjySchdc0V7VZZqx-NwlbWRJ8mH2kKUCSLiPwqkCnks_RYF-sRpMDqTc8YlcR4bpipJXk5uOS4jWAQhZwWVA=\" rel=\"nofollow\" target=\"_blank\">innovation and pipeline development<\/a>. The company\u2019s portfolio includes the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cZ-Kty1Y0aNFI1NxNzF1C8EEbhyfPFXbtjLMcroG9s_wM2EB2FdP9ZUEaNDPOOLFEDd-jR2O9rx9n1VUFr6gas6fv3RPlrDscVGGGwv7pn6HcVQv1lSce4VYSM-TavxSgxRwhLyKqRqQWLlAZRkthdjU_mCmj6Tqfqj02CY5xXw=\" rel=\"nofollow\" target=\"_blank\">Afirma\u00ae Genomic Sequencing Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zPeB6OcEND0v3mJTieOHKQ9V_-5yc9ZQrCJp44a_mbAHpsibdVv_9cxoi3u942e73P7X6oA5JLsFq6EBj_3mt4zt60jKY1qjruxP1E7Vx7Hks4wlysUsWfdcbOHUCWZ4KDPYUj-q_xJIbzHzhAtiW6mCCfkKhvgUibEjZYgBCc0=\" rel=\"nofollow\" target=\"_blank\">Decipher\u00ae Bladder Genomic Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zPeB6OcEND0v3mJTieOHKcZFGZ6D9GNxzVkLUD418L20tD7ehCwcTl9cqqVpiAU1ZfC4uy6LMfDm5_fJtb1XPX77oVxNJ497AnbKXPkj3OdWkFpPhjD40MZ6Zq2squOMUT8Rid-bBhaBFeW0Ix1uPEXrg-xbWHICbFgPV3bU_x8=\" rel=\"nofollow\" target=\"_blank\">Decipher\u00ae Prostate Genomic Classifier test<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JJVQLimy4FTYMCZTh4CyWG6IzMwowDmzuZxPlUev3_pa0o8UPwuvf6mbtSVV0Y5Y1d4w1Ej2PSGOJChMTxgWTz5CZIHrvFwaE8PZIX0RrXpHHWEtlTyY_yuOkqUl8MrndjFD3LWeE17W7IbM-Bn_asPyPVi6qtiMfGPQzbrztaw=\" rel=\"nofollow\" target=\"_blank\">Prosigna\u00ae Breast Risk of Recurrence test<\/a>, and the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jFzb69u4I8_ljs1qYWSYqYMzAilspF1LJY4GDw6YeoaOBdYIw9MwOg8U316IyjVR1hed3ZHtbfVGhuzgN6LYu0NXAlQG8yM2iM-yKk4ytK6SLTojF0ZNrNzOOa-VbCd4692ZGAsUfhbySh4abPnwDg==\" rel=\"nofollow\" target=\"_blank\">TrueMRD\u2122 Monitoring Test for MIBC<\/a>. For more information, visit Veracyte\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sX4DstH9pTEU-9tPcGez-25H-Yd8HzgQPuFnYCqUtIIHym_ube7MQ0WU7m-B0is4DC29eguL1ZfmJqb8ZZ2olQ==\" rel=\"nofollow\" target=\"_blank\">website<\/a>\u00a0or follow the company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OW5M_76n3UxvVcH00iFObpE9Y7wGxTVYhBoKBMiwYm_zchNhf0ipwfRFDxFEfI_QqQgjNXJeh62k77tEH-quuTiIvlAvp9LAoL5wM1MZB7A=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mHc2vtsCH8-jSV0RETWNAIKWik-Tm-ac7eqm5Q16V-atkuYvMPOwo0afkr3JVd2vAJzb_4BqZfrD9IsTCaRnFQ==\" rel=\"nofollow\" target=\"_blank\">X (Twitter)<\/a>.<\/p>\n<p>\n        <strong>Investors<br \/><\/strong>Kelly Gura<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2L2fY1Q2Vj1fvY5B0HbQgssW9H3cCzaGdKlAkl11n2T36zLgapQDg8OKpZ87JWRHELxVGhYZIBo6bF_I-dyCB3oyKEyzwRSk7yOFuSaptBo=\" rel=\"nofollow\" target=\"_blank\">investors@veracyte.com<\/a><\/p>\n<p>\n        <strong>Media<br \/><\/strong>Molly Cornbleet<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GF3ivEtJJ5nKWCuyIj4o3yfowX-MUPmZR8NIVjL16VPRM3oUePD3ak_xfaIPjzoGh0JMhp5WRwEkrk_cuD5KOjdsYqiQw-SBGXlLY5jTXOY=\" rel=\"nofollow\" target=\"_blank\">media@veracyte.com<\/a><br \/>+1-650-351-8780<\/p>\n<p>Source:\u00a0Veracyte, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDVhZjMwZTEtNmEyYi00NTUzLWFkODktYzFkM2QyYzk1MGI3LTEwMTgyNjEtMjAyNi0xMC0xNC1lbg==\/tiny\/Veracyte-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter 2026 after the close of market on Wednesday, November 4, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company\u2019s website and will be available via the following link: https:\/\/edge.media-server.com\/mmc\/p\/kgcmbvpd. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company\u2019s website at https:\/\/investor.veracyte.com\/events-presentations. About VeracyteVeracyte\u00a0(Nasdaq: VCYT) is a global diagnostics &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1010315","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter 2026 after the close of market on Wednesday, November 4, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company\u2019s website and will be available via the following link: https:\/\/edge.media-server.com\/mmc\/p\/kgcmbvpd. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company\u2019s website at https:\/\/investor.veracyte.com\/events-presentations. About VeracyteVeracyte\u00a0(Nasdaq: VCYT) is a global diagnostics &hellip; Continue reading &quot;Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-14T20:31:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026\",\"datePublished\":\"2026-10-14T20:31:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\",\"name\":\"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=\",\"datePublished\":\"2026-10-14T20:31:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","og_locale":"en_US","og_type":"article","og_title":"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) &#8212; Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter 2026 after the close of market on Wednesday, November 4, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. The conference call will be webcast live from the company\u2019s website and will be available via the following link: https:\/\/edge.media-server.com\/mmc\/p\/kgcmbvpd. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company\u2019s website at https:\/\/investor.veracyte.com\/events-presentations. About VeracyteVeracyte\u00a0(Nasdaq: VCYT) is a global diagnostics &hellip; Continue reading \"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-14T20:31:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026","datePublished":"2026-10-14T20:31:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/","name":"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=","datePublished":"2026-10-14T20:31:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0NDMwNCM3ODkxOTc0IzIwMDY2ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/veracyte-to-release-third-quarter-2026-financial-results-on-november-4-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1010315"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1010315\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1010315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1010315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1010315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}